According to AlphaScan data on December 12, social media activity on Injective Protocol (INJ) has steadily increased in the past day and week. This surge in interest has propelled INJ to the second-most mentioned token on social media, trailing only Bitcoin (BTC). Injective Social Media Activity Rising Specifically, data reveals that INJ received nearly 30% of…
Miles Deutscher, a crypto analyst, recently shared insights on altcoins that are catching his attention for the upcoming week. In a post on X, he starts by noting the market’s recent cool-off, suggesting this phase is creating new opportunities for savvy investors. Deutscher also emphasizes the importance of staying informed and ready to capitalize on…
Injective (INJ) has been positive in 2023, racking up a nearly 500% price increase since the turn of the year. This significant rise ranks the cryptocurrency as one of the year’s best-performing assets. Over the past week, the INJ token has been on an upward trend, adding more than 26% to its value. Injective Price…
Injective (INJ) is one of the few tokens to have racked up impressive gains in the last week. While most of the assets in the crypto market were marked by insignificant price actions leading to little gains or losses, INJ stood out with an excellent price movement to become one of the biggest weekly gainers. …
Kaspa (KAS), Injective (INJ), and Render (RNDR) are bucking against the general crypto market trend after sustaining gains over the last day. This follows a bearish movement that occurred after Bitcoin reclaimed the $29,000 level. A flash crash sent the pioneer cryptocurrency back to $27,500 and the crypto market tumbled along with it. However, not…
Injective Protocol has announced that it will expand its partnership with Band Protocol. As such, it will operate a validator node for BandChain. In exchange, Band Protocol will begin participating in Equinox Staking, according to an official post. This is part of Injective Protocol’s testnet preparations for its upcoming mainnet deployment. Injective is a second…